Fox Chase

Clear Genetics is developing a chatbot to help make genetic counseling accessible, and genetic counselors say it could help handle straightforward cases.

The Stanford University and Fox Chase Cancer Center team found that some mutations dramatically increased cancer risk, while others had a more modest effect.

The NGS panel found that a previously diagnosed primary lung tumor was actually metastatic breast cancer, leading to a change in the patient's treatment.

NEW YORK (GenomeWeb News) – RayBiotech announced on Tuesday a partnership to provide biomarker discovery and validation services to the Fox Chase Cancer Center.

Last month, genetic analysis and interpretation firm N of One said that it had interpreted sequence data from over 4,000 tumors, including from whole genomes, exomes, and targeted panels.

Following last week's announcement that Thermo Fisher plans to buy Life Technologies for $13.6 billion, Ion Torrent customers are taking a wait-and-see approach, although many are optimistic that the acquisition could be a boon to Ion Torrent development and to the next-gen seque

Fox Chase Cancer Center has contracted genomics interpretation company N-of-One to interpret and curate results from its new targeted sequencing-based test, CancerCode45, creating reports for ordering physicians that link genomic findings with potential targeted therapies.

NEW YORK (GenomeWeb News) – Molecular data interpretation firm N-of-One today announced a deal with Fox Chase Cancer Center to provide interpretation and treatment strategy services for genome sequencing and testing.

The Fox Chase Cancer Center has begun offering targeted sequencing to inform cancer treatment using an adaptation of Life Technologies' Ion Torrent AmpliSeq Cancer Panel via its CLIA-certified laboratory.

The Cancer Genome Institute at Fox Chase is now offering CancerCode-45, a targeted sequencing-based test that runs on the Ion Torrent platform and screens for mutations to 45 cancer-related genes.

Pages

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.